Susanne E. Aydin,,Sara Sebnem Kilic,Caner Aytekin,Ashish Kumar,Oscar Porras,Leena Kainulainen,Larysa Kostyuchenko,Ferah Genel,Necil Kütükcüler,Neslihan Karaca,Luis Gonzalez-Granado,Jordan Abbott,Daifulah Al-Zahrani,Nima Rezaei,Zeina Baz,Jens Thiel,Stephan Ehl,László Marodi,Jordan S. Orange,Julie Sawalle-Belohradsky,Sevgi Keles,Steven M. Holland,Özden Sanal,Deniz C. Ayvaz,Ilhan Tezcan,Hamoud Al-Mousa,Zobaida Alsum,Abbas Hawwari,Ayse Metin,Susanne Matthes-Martin,Manfred Hönig,Ansgar Schulz,Capucine Picard,Vincent Barlogis,Andrew Gennery,Marianne Ifversen,Joris van Montfrans,Taco Kuijpers,Robbert Bredius,Gregor Dückers,Waleed Al-Herz,Sung-Yun Pai,Raif Geha,Gundula Notheis,Carl-Philipp Schwarze,Betül Tavil,Fatih Azik,Kirsten Bienemann,Bodo Grimbacher,Valerie Heinz,H. Bobby Gaspar,Roland Aydin,Beate Hagl,Benjamin Gathmann,Bernd H. Belohradsky,Hans D. Ochs,Talal Chatila,Ellen D. Renner,Helen Su,Alexandra F. Freeman,Karin Engelhardt,Michael H. Albert,

Abstract:Mutations in DOCK8 result in autosomal recessive Hyper-IgE syndrome with combined immunodeficiency (CID). However, the natural course of disease, long-term prognosis, and optimal therapeutic management have not yet been clearly defined. In an international retrospective survey of patients with DOCK8 mutations, focused on clinical presentation and therapeutic measures, a total of 136 patients with a median follow-up of 11.3 years (1.3–47.7) spanning 1693 patient years, were enrolled. Eczema, recurrent respiratory tract infections, allergies, abscesses, viral infections and mucocutaneous candidiasis were the most frequent clinical manifestations. Overall survival probability in this cohort [censored for hematopoietic stem cell transplantation (HSCT)] was 87 % at 10, 47 % at 20, and 33 % at 30 years of age, respectively. Event free survival was 44, 18 and 4 % at the same time points if events were defined as death, life-threatening infections, malignancy or cerebral complications such as CNS vasculitis or stroke. Malignancy was diagnosed in 23/136 (17 %) patients (11 hematological and 9 epithelial cancers, 5 other malignancies) at a median age of 12 years. Eight of these patients died from cancer. Severe, life-threatening infections were observed in 79/136 (58 %); severe non-infectious cerebral events occurred in 14/136 (10 %). Therapeutic measures included antiviral and antibacterial prophylaxis, immunoglobulin replacement and HSCT. This study provides a comprehensive evaluation of the clinical phenotype of DOCK8 deficiency in the largest cohort reported so far and demonstrates the severity of the disease with relatively poor prognosis. Early HSCT should be strongly considered as a potential curative measure.

A novel homozygous DOCK8 mutation associated with unusual coexistence of gross molluscum contagiosum and epidermodysplasia verruciformis in a DOCK8 deficiency patient.

[Combined immunodeficiency due to DOCK8 deficiency. State of the art]

A Novel Mutation Within the 2B Rod Domain of Keratin 9 in a Chinese Pedigree with Epidermolytic Palmoplantar Keratoderma Combined with Knuckle Pads and Camptodactyly

Dedicator of cytokinesis 8 (DOCK8) mutation impairs the differentiation of helper T cells by regulating the glycolytic pathway of CD4+ T cells

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

Identification of LCK Mutation in a Family with Atypical Epidermodysplasia Verruciformis with T-cell Defects and Virus-Induced Squamous Cell Carcinoma.

Successfully treated with siltuximab and prednisone in a 7-year-old girl with DOCK8-deficiency presenting as recurrent wart-like lesions: a case report

Identification and Splicing Characterization of Novel TMC6 and TMC8 Variants Associated With Epidermodysplasia Verruciformis in Three Chinese Families

DOCK8 gene mutation alters cell subsets, BCR signaling, and cell metabolism in B cells

Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency

A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families

A Novel Heterozygous Nonsense Mutation of Keratin 5 in a Chinese Family with Dowling–Degos Disease

Hyper-IgE Syndrome Caused by DOCK8 Mutation with a Tumour-Like Lesion of the Lip: a Case Report

DOCK2-deficiency causes defects in anti-viral T cell responses and impaired control of herpes simplex virus infection

Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency

Dystrophic Epidermolysis Bullosa Characterized by Mucosal Lesions in a Chinese Familial Case with a Novel Compound Heterozygous Mutation of COL7A1.

Next-Generation Sequencing Detection and Characterization of A Heterozygous Novel Splice Junction Mutation in the 2b Domain of Krt1 in A Family with Diffuse Palmoplantar Keratoderma

DOCK8 is critical for the survival and function of NKT cells

P27 Successful treatment of severe eczema and plane warts with Dupilumab in a child with Dedicator of Cytokinesis 8 (DOCK8) deficiency (Autosomal recessive form of hyper-IgE syndrome)

DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

Identification Of A Novel Mutation And A De Novo Mutation In Dkc1 In Two Chinese Pedigrees With Dyskeratosis Congenita